TrialRadiation oncology (London, England)2022

A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer.

S Kawakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.